Cited by 168Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCoronary Interventions and Diagnostics

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Non–High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI)

Bittner, Vera, Hardison, Regina, Kelsey, Sheryl F., Weiner, Bonnie H., Jacobs, Alice K., Sopko, George·2002·Circulation

DOI 10.1161/01.cir.0000038496.57570.06

Open this paper in CoChat — free account

Abstract

Background— Current National Cholesterol Education Program guidelines recommend that non–high-density lipoprotein cholesterol (non-HDL-C) be considered a secondary target of therapy among individuals with triglycerides >2.26 mmol/L. It is not known whether non-HDL-C relates to prognosis among patients with coronary heart disease. Methods and Results— Lipid levels were available at baseline among 1514 patients (73% men; mean age, 61 years) enrolled in the Bypass Angioplasty Revascularization Investigation (BARI); all had multivessel coronary artery disease. Patients were followed for 5 years. Outcomes of death, nonfatal myocardial infarction, and death or myocardial infarction were modeled using univariate and multivariate time-dependent proportional hazards methods; angina pectoris at 5 years was modeled using univariate and multivariate logistic regression. Non-HDL-C was a strong and independent predictor of nonfatal myocardial infarction (multivariate relative risk, 1.049 [95% confidence intervals, 1.006 to 1.093] for every 0.26 mmol/L increase) and angina pectoris (multivariate odds ratio, 1.049 [95% confidence intervals, 1.004 to 1.096] for every 0.26 mmol/L increase), but it did not relate to mortality. HDL-C and LDL-C did not predict events during follow-up. Conclusions— Among patients with lipid values in BARI, non-HDL-C is a strong and independent predictor of nonfatal myocardial infarction and angina pectoris at 5 years, even after consideration of powerful clinical variables. Our data suggest that non-HDL-C is an appropriate treatment target among patients with coronary heart disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000038496.57570.06

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843
The National Cholesterol Education Program
Cleeman, J. I. (1989) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30638-3 · Cited by 711
Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Cui, Y. A., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., LANGENBERG, P. W., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 657
Dyslipidemia and Hyperglycemia Predict Coronary Heart Disease Events in Middle-Aged Patients With NIDDM
Lehto, S., Rönnemaa, T., Haffher, S. M., Pyörälà, K., Kallio, V., & Laakso, M. (1997) · Diabetes · doi:10.2337/diab.46.8.1354 · Cited by 374
Rationale for Use of Non–High-Density Lipoprotein Cholesterol Rather Than Low-Density Lipoprotein Cholesterol as a Tool for Lipoprotein Cholesterol Screening and Assessment of Risk and Therapy
Frost, P. H., & Havel, R. J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00034-4 · Cited by 193
Serum Lipids and Incidence of Coronary Heart Disease
Frost, P. H., Davis, B. R., Burlando, A. J., Curb, J. D., Guthrie, G. P., Isaacsohn, J. L., Wassertheil-Smoller, S. W., Wilson, A. C., & Stamler, J. (1996) · Circulation · doi:10.1161/01.cir.94.10.2381 · Cited by 147
High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.
Pocock, S., Shaper, A. G., Phillips, A. N., Walker, M., & Whitehead, T. P. (1986) · BMJ · doi:10.1136/bmj.292.6519.515 · Cited by 127

Show all 16 references

Research works printed but not linked: 4

1992, Acta Cardiol, 47, 311
10.1161/circ.94.10.2381 · DOI
10.1161/circ.84.1.1647896 · DOI
10.1161/circ.101.23.2682 · DOI

Sorted by citations

Items 101–166 of 166

Non-HDL Cholesterol and Atherosclerotic Cardiovascular Disease.
Puri, R., Mehta, V., Iyengar, S. S., Narasingan, S. N., Duell, P. B., Sattur, G. B., Vijayaraghavan, K., Mohan, J. C., Wangnoo, S. K., Dalal, J. J., et al. (2020) · PubMed · Cited by 7
The Ankle Brachial Index Exhibits Better Association of Cardiovascular Prognosis Than Non–High-Density Lipoprotein Cholesterol in Type 2 Diabetes
Chang, L.-H., Hwu, C., Chu, C., Won, J. G. S., Kwok, C., Lin, H.-D., Chen, H.-S., Lin, Y., & Lin, L. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.02.035 · Cited by 6
A Proposal for the Optimal Management Target for Serum Non-High-Density Lipoprotein Cholesterol Level in Low-Risk Japanese Workers
Saiki, Y., Otsuka, T., Kato, K., & Kawada, T. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33068 · Cited by 7
Increased Non-High-Density Lipoprotein Cholesterol in Children and Young Adults with Turner Syndrome Is Not Explained By BMI Alone
Kelley, J. C., Gutmark‐Little, I., Backeljauw, P. F., & Bamba, V. (2017) · Hormone Research in Paediatrics · doi:10.1159/000477761 · Cited by 7
Limitations of current screening methods for lipid disorders in Korean adolescents and a proposal for an effective detection method: a nationwide, cross-sectional study
Shin, J. H., Cheong, J. I., Cheuh, H. W., & Yoo, J. H. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040098.049 · Cited by 7
Cholesterol and Triglyceride Management
Braun, L. T. (2010) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181cec6d1 · Cited by 7
Intensive statin therapy for Indians: Part-I. Benefits.
Enas, E. A., Pazhoor, H. C., Kuruvila, A. T., & Vijayaraghavan, K. (2011) · PubMed · Cited by 7
Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment
Athyros, V. G., Papageorgiou, A. A., Symeonidis, A. N., & Elisaf, M. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00128-x · Cited by 7
Cross-Sectional Study of Arterial Stiffness in Adolescents with Down Syndrome
Kelly, A. T., Magge, S. N., Walega, R., Cochrane, C. I., Pipan, M. E., Zemel, B. S., Cohen, M. S., Gidding, S. S., & Townsend, R. R. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.04.059 · Cited by 6
Re-Evaluating Therapeutic Target Goals for Statin-Treated Patients
Henkin, Y. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.018 · Cited by 5
Triglycerides and Cardiovascular Disease : A Scientific Statement From the
Pennathur, S., Kris‐Etherton, P. M., Lennie, T. A., Levi, M., Mazzone, T., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Stone, N. J., Ballantyne, C. M., et al. (2011) · Cited by 6
Self-citation
Advances in Lipid Testing and Management in Patients with Diabetes Mellitus
Vasudevan, M. M., & Ballantyne, C. M. (2009) · Endocrine Practice · doi:10.4158/ep09190.ra · Cited by 5
Elevated remnant cholesterol and non-HDL cholesterol concentrations from real-world laboratory results: a cross-sectional study in Southeast Asians
Loh, W. J., Soh, H. S., Tun, M. H., Tan, P. T., Lau, C. S., Subramaniam, T., Watts, G. F., & Aw, T. C. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1328618 · Cited by 5
Evaluation of pattern of dyslipidemia in type 2 diabetics in Swat
Jan, S. S., Rehman, A., Ahmad, R. M., Khan, T. M., Ahmad, A., & Abrar, A. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5
Non-high-density cholesterol level as a predictor of maximum carotid intima-media thickness in Japanese subjects with type 2 diabetes: a comparison with low-density lipoprotein level
Bando, Y., 若栗ひとみ, Aoki, K., Kanehara, H., Hisada, A., Okafuji, K., Toya, D., & Tanaka, N. (2015) · Diabetology International · doi:10.1007/s13340-015-0208-0 · Cited by 5
Assessment of Serum Atherogenic Indices and Insulin Resistance in Retinal Vein Occlusion
Gönül, Ş., & Eker, S. (2024) · Turkish Journal of Ophthalmology · doi:10.4274/tjo.galenos.2024.66367 · Cited by 4
Nomograms Based on Non-High-Density Lipoprotein to Predict Outcomes in Patients with Prior Coronary Artery Bypass Grafting with Acute Coronary Syndrome: A Single-Center Retrospective Study
Li, C., He, K., Yang, Y., Li, K., Chen, M., Wang, L., Xu, X., & Li, W. (2023) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s389694 · Cited by 4
Relationship between Lipid Indices, Type IV Collagen Turnover and the Development of Microvascular Complications in Diabetic Patients with Arterial Hypertension
NIKOLOV, A. G., Tzekova, M., & Blazhev, A. B. (2019) · Folia Medica · doi:10.2478/folmed-2018-0072 · Cited by 4
Comparison of Therapeutic Lipid Target Achievements Among High-Risk Patients in Oman
Al-Waili, K., Al-Zakwani, I. S., Al‐Dughaishi, T., Baneerje, Y., Al-Sabti, H. A., Al-Hashmi, K., Farhan, H., Habsi, K. A., Al-Hinai, A. T., & Al‐Rasadi, K. (2013) · Angiology · doi:10.1177/0003319713482572 · Cited by 4
Utility of Advanced Lipoprotein Testing in Clinical Practice
Feingold, K. R., & Grünfeld, C. (2016) · Europe PMC (PubMed Central) · Cited by 4
Relation of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio to residual risk in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF Project III cohort
Soler‐Espejo, E., Chen, Y., Rivera‐Caravaca, J. M., Ramos‐Bratos, M. P., Esteve‐Pastor, M. A., Marín, F. R., Roldán, V., & Lip, G. Y. H. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02927-x · Cited by 3
The relevance of remnant cholesterol as a guide for lipid management in Indian subjects undergoing coronary revascularization
Bansal, M., Kasliwal, R. R., Chandra, P., Kapoor, R., Chouhan, N., Bhan, A., & Trehan, N. K. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103183 · Cited by 3
Attitudes toward Hormone Replacement Therapy in the New Millennium: University Physicians’ and Patients’ Perspectives
Ismail, H. M., Aleveritis, E., Guha, B., Olive, K. E., & Sloan, S. M. (2005) · Journal of Investigative Medicine · doi:10.2310/6650.2005.53606 · Cited by 3
Baseline and longitudinal patterns of Non-HDL-C to HDL-C ratio (NHHR) and major adverse cardiovascular events in peripheral artery disease
Zhang, Y., Jing, Z., Liu, Z., Lai, A., Tan, G., & Yan, B. P. (2025) · Scientific Reports · doi:10.1038/s41598-025-19856-0 · Cited by 2
Consensus Interdisciplinary Positions of the Metabolic Syndrome Supervisory Committee
Shlyakhto, E. V., Arutyunov, G. P., Babenko, A. Y., Boytsov, S. A., Вадимовна, В. С., Dedov, I. I., Drapkina, O. M., Олеговна, Е. С., Звартау, Н. Э., Ivashkin, V. T., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-7130 · Cited by 3
Association between atherogenic index of plasma and left ventricular hypertrophy in patients with chronic heart failure with mid-range ejection fraction
NIKOLOV, A. G., Blazheva, S. O., Kostadinovska, A., Kostov, K., & Tzekova, M. (2022) · Medicina Fluminensis · doi:10.21860/medflum2022_271160 · Cited by 2
Non-HDL Estimation Methods: Advancing Cardiovascular Disease Prediction
Akbar, A. M., Jha, D., Ali, H., & Ahmad, T. (2023) · Indian Journal of Pharmacy Practice · doi:10.5530/ijopp.16.4.52 · Cited by 2
Lipoproteins and Cardiovascular Disease Risk
Dhingra, R., & Vasan, R. S. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_4 · Cited by 2
Mycotic aneurysm of the ascending aorta: an unusual infectious complication of left ventricular assist device explantation
Combes, S., Chabrot, P., & Camilleri, L. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn617 · Cited by 2
Advanced Lipid Testing
Sorrentino, M. J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-502-6_5 · Cited by 1
Novel Lipids Targets in the Era of Metabolic Syndrome
Paneni, F., Palano, F., & Testa, M. (2009) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/11316980-000000000-00000 · Cited by 1
Translation: Non-HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population
van Deventer, H. E., Miller, W. G., Myers, G. L., Sakurabayashi, I., Bachmann, L. M., Caudill, S. P., Dziekoński, A., Edwards, S. H., Kimberly, M. M., Korzun, W. J., et al. (2011) · Laboratory Medicine Online · doi:10.3343/lmo.2011.1.3.1 · Cited by 1
ASSOCIATION OF NON-HDL CHOLESTEROL WITH RISK OF CARDIOVASCULAR DISEASE DEFINED BY TOTAL CHOLESTEROL/ HDL-CHOLESTEROL RATIO
Pallavi, B., & Krishnamurthy, U. (2016) · International Journal of Pharma and Bio Sciences · Cited by 1
Cacao Polyphenols Influence the Regulation of Apolipoproteins
Osakabe, N. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00074-8 · Cited by 1
The Contribution of Triglycerides and Triglyceride-Rich Lipoproteins to Atherosclerotic Cardiovascular Disease
Welty, F. K. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00015-9 · Cited by 1
Stunted Growth Is Associated With Dyslipidemia in Young Adults With Perinatal HIV Infection
Lesiapeto, M., Justine Shults, A., Mmunyane, M., Matshaba, M., & Lowenthal, E. D. (2023) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003209 · Cited by 1
Association between the variability of non-high-density lipoprotein cholesterol and the neutrophil-to-lymphocyte ratio in patients with coronary heart disease
Chen, Y., Zhang, S., Tao, Y., Hu, W., Li, D., Shen, X., Li, Y., Lin, M., Zhang, W., Liu, X., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1254125 · Cited by 1
CORRELATION OF LIPID PROFILE WITH CAROTID INTIMA MEDIA THICKNESS IN NEWLY DIAGNOSED CORONARY ARTERY DISEASE PATIENTS.
Ashfaque, J., & PrakrithiM, D. (2017) · International Journal of Advanced Research · doi:10.21474/ijar01/5921 · Cited by 1
Niveles de colesterol no HDL en la población chilena y su asociación con enfermedad cardiovascular y diabetes mellitus: estudio de corte transversal en Encuesta Nacional de Salud 2009-2010
ALÉ, M. C., Echeverría, G., Jugo, A., Villarroel, L. A., Alberto Maiz, G., & Rigotti, A. (2019) · Revista médica de Chile · doi:10.4067/s0034-98872019001101365 · Cited by 1
Levels of non-high-density-lipoprotein cholesterol are positively correlated with the risk of cognitive impairment in patients with intracerebral hemorrhage stroke
Wang, Z., Li, M., Song, Y., & Peng, R. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1849192 · Cited by 1
Dyslipidemia
Diniz, E. T., & Bandeira, F. A. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_40 · Cited by 1
Concerns About the Use of Non-High-Density Lipoprotein Cholesterol as a Lipid Predictor
Feeman, W. E. (2017) · European Medical Journal · doi:10.33590/emj/10312180 · Cited by 1
Avaliação nutricional de crianças a adolescentes portadores de imunodeficiências primárias e sua relação com os componentes da síndrome metabólica
Maneschy, I. R. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2015.tde-24082015-092045 · Cited by 1
Practice Patterns in Treating High-Risk Patients with Hyperlipidemia at a Northeast Tennessee University Clinic
Ismail, H. M., Simmons, C. A., & Pfortmiller, D. T. (2005) · Journal of Investigative Medicine · doi:10.2310/6650.2005.00003 · Cited by 1
Achieving National Cholesterol Education Program Goals in Coronary Artery Disease
Rondina, M. T., & Zebrack, J. S. (2005) · Preventive Cardiology · doi:10.1111/j.1520-037x.2005.3757.x · Cited by 1
Non-HDL-cholesterol and total cholesterol to HDL-C ratio in abdominally obese adults in Phitsanulok.
Tangvarasittichai, S., Tangvarasittichai, O., Teeraputon, S., Maneemaroj, R., Boonlert, W., Jongjitwimol, J., Wongseana, W., Jermsri, P., Meemark, S., & Sangaroon, N. (2009) · DOAJ (DOAJ: Directory of Open Access Journals)
Monitoring of Lipids in Diabetes
Laker, M. F., & Neely, R. D. G. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0807
Analyse von Proteinen und deren Elimination durch drei verschiedene extrakorporale Therapieverfahren der LDL-Apherese bei Patienten mit familiärer Hypercholesterinämie mittels Proteomics-Methoden
Söllner, T. (2010) · doi:10.53846/goediss-860
Dyslipidemia: The Role of Non-HDL Cholesterol, Apolipoprotein B and Small, Dense LDL
Papadopoulou, E., Stathopoulou, P., & Manolis, A. S. (2008) · Hospital chronicles/Hospital Chronicles
Laboratory-based versus non-laboratory-based CVD risk analysis
Niederseer, D., & Niebauer, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60909-5
Laboratory-based versus non-laboratory-based CVD risk analysis
Ballo, P., Bocelli, A., & Mondillo, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60911-3
Is Non–High-Density Lipoprotein Cholesterol a Marker and Therapeutic Target for Dyslipidemia in Metabolic Syndrome?
Vega, G. L. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.1503
Non-HDL cholesterol, total cholesterol/HDL cholesterol and LDL-cholesterol levels in patients with acute ischemic stroke
Boğdaycıoğlu, N., Ercan, M., Uysal, S., Mungan, S., & Yılmaz, F. M. (2013) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.5350/semb2013470405
The development and testing of an instrument for measuring awareness of coronary heart disease risk factors reduction in a Hong Kong Chinese population
Chan, C. W. (2008) · Research Bank (Australian Catholic University) · doi:10.4226/66/5a95e31fc67fb
Kardiovaskuläre Hochleistungsmedizin - ohne integrierte Nachsorgemodelle?
Lotz, N. (2003) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American
Lennie, T. A., Levi, M., Mazzone, T., Pennathur, S., Goldberg, A. C., Howard, W. J., Jacobson, M. Z., Stone, N. J., Ballantyne, C. M., Bittner, V., et al. (2013)
Self-citation
New trends in lipid management: eight cases to consider.
Smith, D. A. (2005) · PubMed
Effect of lipid parameters on carotid artery disease progression in patients undergoing carotid endarterectomy and unoperated patients with non-severe carotid artery stenosis
Özsin, K. K., Sanrı, U. S., Toktaş, F., Şeker, İ. B., & Yavuz, Ş. (2018) · The European Research Journal · doi:10.18621/eurj.444384
Lipid Indices, Elastin Turnover and the Development of Microvascular Complications – A Study in Diabetic Patients with Arterial Hypertension
NIKOLOV, A. G., Blazhev, A. B., Tzekova, M., Kostov, K. G., & Popovski, N. K. (2019) · Acta Medica Bulgarica · doi:10.2478/amb-2019-0004
Evolving Targets of Therapy
Barter, P. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50036-6
Dyslipidemia
Diniz, E. T., Cardoso, A. C. S., & Bandeira, F. A. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_44
Emerging Markers for Cardiovascular Risk Assessment
周, 文. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12101324
Discordance of Circulating Non-HDL Cholesterol with LDL Cholesterol Concerning Long-Term Prognosis in Statin-Treated Individuals with Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting Undergoing Percutaneous Coronary Intervention
Li, C., He, K., Yang, Y., Li, K., Chen, M., Wang, L., Gao, Y., & Xu, X. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2409263
Cardiovascular Disease Risk and Risk Reduction Strategies in Diabetes Mellitus
Wilson, D. P., Hamilton, L., & Maki, K. C. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_14
Investigation of thyroid function tests and lipid levels in cerebrovascular patients
Çambay, Z., Adsiz, T., Keser, S., & Domaç, F. M. (2024) · Journal of Physical Chemistry and Functional Materials · doi:10.54565/jphcfum.1459969
Serum High-Density Lipoprotein Cholesterol level in patients suffering from sepsis, measured on the first and fifth day of admission, and its relation with prognosis
Chakraborty, M., Choudhury, B., Bhowal, R., & Tripura, K. (2024) · International journal of life sciences, biotechnology and pharma research. · doi:10.69605/ijlbpr_13.6.13

Authors: Bittner, V., Hardison, R., Kelsey, S. F., Weiner, B. H., Jacobs, A. K., & Sopko, G.
Affiliations: Boston University (US)
ORCID: Bittner, Vera
Weiner, Bonnie H.
Jacobs, Alice K.
Sopko, George
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2002-11-12
Volume: 106
Issue: 20
Pages: 2537-2542
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000038496.57570.06
OpenAlex: W2113541168
Cited by: 168
References: 16
Citations by year: 2026: 1 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 5 · 2021: 1 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 6 · 2014: 5 · 2013: 13 · 2012: 4
FWCI: 9.86
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5u01hl038532-11, 5u01hl038504-10, 5u01hl038556-10, 5u01hl038512-10, 5u01hl038642-11, 2u01hl038514-09, 5u01hl038509-10, 5u01hl038518-11, 5u01hl038529-11, 2u01hl038524-09, 2u01hl038493-09)
National Heart, Lung, and Blood Institute (HL 38610, HL-38509, HL42145, HL-38529, HL38514-6, HL38556, HL-38493, HL-38532, HL38642, HL-38504, HL-38518, HL 38512, U01HL038610, HL38524)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Keywords: non-HDL cholesterol, coronary artery disease, multivessel coronary artery disease, nonfatal myocardial infarction, angina pectoris, cardiovascular mortality, prognostic factors, triglycerides, HDL cholesterol, LDL cholesterol
MeSH terms: Angina Pectoris, Coronary Artery Bypass, Cholesterol, Coronary Artery Disease, Female, Follow-Up Studies, Humans, Lipoproteins, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Myocardial Infarction, Prognosis, Risk, Triglycerides, Angioplasty, Balloon, Coronary, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Non–High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks